These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1973495)

  • 1. Intermittent co-trimoxazole prophylaxis against Pneumocystis carinii pneumonia.
    Raviglione MC; Nsah EN; Cortes H; Mariuz P; Sanjana V
    Lancet; 1990 Jul; 336(8708):180. PubMed ID: 1973495
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease.
    Ruskin J; LaRiviere M
    Lancet; 1991 Feb; 337(8739):468-71. PubMed ID: 1671479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia.
    Mallolas J; Zamora L; Gatell JM; Miró JM; Soriano E
    Lancet; 1991 May; 337(8750):1162-3. PubMed ID: 1674036
    [No Abstract]   [Full Text] [Related]  

  • 4. Dilemmas in the prophylaxis of Pneumocystis carinii pneumonia.
    Glatt AE
    South Med J; 1994 Apr; 87(4):429-30. PubMed ID: 8153765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Question 1: Co-trimoxazole dosing dilemma: what is the right dose?
    Boast A; Osowicki J; Cole T; Curtis N; Gwee A
    Arch Dis Child; 2015 Nov; 100(11):1089-93. PubMed ID: 26408788
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing?
    Miller RF
    Thorax; 2000 Aug; 55 Suppl 1(Suppl 1):S15-22. PubMed ID: 10943633
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-dose intermittent trimethoprim-sulfamethoxazole for prevention of Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection.
    Wormser GP; Horowitz HW; Duncanson FP; Forseter G; Javaly K; Alampur SK; Gilroy SA; Lenox T; Rappaport A; Nadelman RB
    Arch Intern Med; 1991 Apr; 151(4):688-92. PubMed ID: 1901482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia.
    Castellano AR; Nettleman MD
    JAMA; 1991 Aug; 266(6):820-4. PubMed ID: 1907671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS.
    JAMA; 1988 Aug; 260(7):921-2. PubMed ID: 3260965
    [No Abstract]   [Full Text] [Related]  

  • 10. Pneumocystis carinii pneumonia: therapy and prophylaxis.
    Kovacs JA; Masur H
    J Infect Dis; 1988 Jul; 158(1):254-9. PubMed ID: 2969023
    [No Abstract]   [Full Text] [Related]  

  • 11. The acquired immune deficiency syndrome: problems associated with the management of Pneumocystis carinii pneumonia.
    Farthing CF; Shanson DC; Gazzard BG
    J Infect; 1985 Sep; 11(2):103-8. PubMed ID: 3877121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Sulfamethoxazole-Trimethoprim on Airway Colonization with Pneumocystis jirovecii.
    Kushima H; Ishii H; Tokimatsu I; Umeki K; Sato T; Kadota J
    Jpn J Infect Dis; 2016 May; 69(3):252-5. PubMed ID: 26255727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole once a day twice a week.
    Bostrom BC
    Pediatr Blood Cancer; 2009 Aug; 53(2):239. PubMed ID: 19422030
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylaxis against Pneumocystis carinii pneumonia.
    Gabin SJ
    JAMA; 1992 Apr; 267(13):1779. PubMed ID: 1545462
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ.
    Gluckstein D; Ruskin J
    Clin Infect Dis; 1995 Apr; 20(4):849-53. PubMed ID: 7795084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From the Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus.
    JAMA; 1989 Jul; 262(3):335-9. PubMed ID: 2525628
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of prophylaxis against Pneumocystis carinii on toxoplasma encephalitis.
    Zangerle R; Allerberger F
    Lancet; 1991 May; 337(8751):1232. PubMed ID: 1673776
    [No Abstract]   [Full Text] [Related]  

  • 18. Failures of once-a-week trimethoprim-sulfamethoxazole prophylaxis in children undergoing allogeneic hematopoietic stem cell transplant.
    Castagnola E; Mesini A; Saffioti C; Moscatelli A; Pierri F; Giardino S; Faraci M
    Transpl Infect Dis; 2020 Feb; 22(1):e13231. PubMed ID: 31846143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014.
    Cooley L; Dendle C; Wolf J; Teh BW; Chen SC; Boutlis C; Thursky KA
    Intern Med J; 2014 Dec; 44(12b):1350-63. PubMed ID: 25482745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-trimoxazole versus dapsone-pyrimethamine for prevention of Pneumocystis carinii pneumonia.
    Coker RJ; Nieman R; McBride M; Mitchell DM; Harris JR; Weber JN
    Lancet; 1992 Oct; 340(8827):1099. PubMed ID: 1357487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.